Description

Key Benefits of Briganix 180 mg (Brigatinib)

1. Highly Effective for ALK-Positive NSCLC: Briganix 180 mg is approved for treating ALK-positive non-small cell lung cancer (NSCLC) in patients whose cancer has progressed despite other treatments. It provides targeted therapy that inhibits the ALK gene mutation, helping to stop the growth and spread of cancer cells.

2. Improves Progression-Free Survival: Clinical studies have shown that Brigatinib significantly extends progression-free survival, helping to delay the spread of cancer and offering patients improved long-term outcomes.

3. Effective Against Brain Metastases: One of the standout features of Briganix 180 mg is its ability to cross the blood-brain barrier and reduce tumour growth in patients with brain metastases from ALK-positive NSCLC. This provides an effective treatment option for patients with cancer that has spread to the brain.

4. Convenient Oral Treatment: Briganix is a once-daily oral therapy, allowing patients to take the medication at home without needing hospital visits. This provides a more convenient and non-invasive option for managing advanced lung cancer.

How Does Briganix 180 mg (Brigatinib) Work?

Briganix 180 mg contains Brigatinib, a next-generation tyrosine kinase inhibitor (TKI) that targets and inhibits the anaplastic lymphoma kinase (ALK) gene mutation. This mutation drives the growth and spread of cancer cells in ALK-positive NSCLC. By blocking the ALK protein, Brigatinib prevents cancer cells from multiplying and spreading, helping to control disease progression. In addition, Brigatinib is effective in treating cancer that has metastasized to the brain, making it a powerful option for patients with advanced disease.

Who Should Use Briganix 180 mg?

Briganix 180 mg is recommended for: 

1. Adults with ALK-positive non-small cell lung cancer (NSCLC), particularly those whose cancer has progressed after treatment with crizotinib or other ALK inhibitors.
2. Patients with brain metastases from ALK-positive NSCLC, as Briganix has been shown to reduce tumour size and slow cancer progression in the brain.

Dosage and Usage

The recommended dosage of Briganix is 180 mg once daily, following a 7-day starting dose of 90 mg once daily to help the body adjust to the treatment. Briganix should be taken simultaneously each day, with or without food. It is essential to follow your healthcare provider’s instructions closely and attend regular check-ups to monitor your response to the medication and manage any potential side effects.

Side Effects of Briganix 180 mg

While Briganix 180 mg is highly effective in treating ALK-positive NSCLC, some patients may experience side effects, including:
– Nausea
– Fatigue
– Diarrhea
– Cough
– Hypertension (high blood pressure)
– Vision disturbances

In rare cases, serious side effects, such as lung problems, high blood pressure, or blood clots, may occur. It is important to report any severe or unusual symptoms to your healthcare provider.

Why Choose Briganix 180 mg (Brigatinib)?

– Specifically Targets ALK Mutation: Briganix 180 mg offers a targeted approach to treating ALK-positive lung cancer. Inhibiting the ALK gene mutation addresses the root cause of cancer growth.
– Improves Survival Rates: Brigatinib has been proven to extend progression-free survival, helping patients live longer and better manage their cancer.
– Effective for Brain Metastases: Briganix is one of the few ALK inhibitors that can cross the blood-brain barrier and treat cancer that has spread to the brain, offering hope to patients with advanced disease.
– Convenient Oral Treatment: With once-daily dosing, Briganix provides a convenient and non-invasive option for patients, making it easier to incorporate into daily life.

Take Control of ALK-Positive NSCLC with Briganix 180 mg.

Suppose you or a loved one has been diagnosed with ALK-positive non-small cell lung cancer, particularly after previous treatments have failed. In that case, Briganix 180 mg (Brigatinib) offers a powerful, targeted therapy to help manage the disease. With its ability to slow cancer progression and treat brain metastases, Briganix provides a comprehensive treatment approach that can improve survival and quality of life.

Order Briganix 180 mg today and consult your oncologist to see if this advanced therapy is the right option for your lung cancer treatment plan.